EVENTIDE ASSET MANAGEMENT, LLC
CIK 1442891 · EDGAR ↗
- sum of disclosed values for 2026-03-31; 0 positions have no disclosed value and are left out of the sum, counted here rather than dropped
- $6.0B
- every reported holding for this filer and quarter, including ones with no disclosed value
- 278
- positions with no comparable holding in the prior quarter (kind new), 2026-03-31
- 46
- positions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record
- 36
Quarter-end snapshot, filed up to 45 days later — not current holdings. What a 13F covers ↓
Changes · Quarter ended 2026-03-31. Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
by shares · How classified ↗Period
| The reviewed ticker for the filed issuer name and share class, the same mapping the Reported positions table uses. Symbols are never inferred from names; — means no reviewed mapping. | position matched across quarters by exact reported CUSIP over a registry gap — never a name match | NEW / ADD / TRIM / EXIT by share count · NO CHANGE = same shares; the value moved with price, so never an ADD or a TRIM · EXIT = absent this quarter (disposed, delisted, confidential, or reported by an affiliate) — the filing does not say which · NO PRIOR = no comparable prior quarter on record (a first filing, or a quarter filed inside an affiliate's report), so not called a new stake · n/c = not classifiable: value undisclosed on one side of the pair, or neither shares nor value can classify it · †v: the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE | derived by Public Filings from the published data; “no value” means the source did not disclose a usable value — never zero | Prev value | Curr value | Prev shares | Curr shares | |
|---|---|---|---|---|---|---|---|---|
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:17626 · issuer key iss:860 | TRIM | −$38.4M | −148,712 | $256M | $218M | 2,511,091 | 2,362,379 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: SHS · position key pos:14081 · issuer key iss:2235 | ADD | +$12.0M | +3,281 | $157M | $169M | 403,274 | 406,555 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM NEW · position key pos:10455 · issuer key iss:1091 | ADD | +$31.9M | +19,313 | $115M | $147M | 669,089 | 688,402 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:11504 · issuer key iss:1236 | TRIM | −$35.3M | −684,711 | $165M | $130M | 2,093,582 | 1,408,871 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:13890 · issuer key iss:1760 | ADD | +$37.1M | +21,737 | $88.7M | $126M | 480,550 | 502,287 |
| — | share class as filed: CLASS A COM · position key sid:sec:prov:e2e110d836d8ffc2e5f76e7fa0612596 · issuer key cusip6:98423F | ADD | −$53.9M | +24,113 | $175M | $121M | 2,936,126 | 2,960,239 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:17386 · issuer key iss:806 | TRIM | −$6.8M | −53,922 | $122M | $116M | 187,122 | 133,200 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:10426 · issuer key iss:1352 | TRIM | +$19.7M | −18,953 | $95.8M | $115M | 610,644 | 591,691 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:17712 · issuer key iss:1630 | TRIM | +$827K | −233,948 | $107M | $108M | 2,431,333 | 2,197,385 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: SPONSORED ADR · position key pos:17260 · issuer key iss:165 | ADD | −$10.2M | +4,436 | $102M | $91.7M | 121,221 | 125,657 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: N Y REGISTRY SHS · position key pos:11625 · issuer key iss:2284 | ADD | +$18.4M | +1,290 | $71.5M | $89.9M | 66,820 | 68,110 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:12344 · issuer key iss:946 | ADD | −$33.1M | +68,339 | $123M | $89.8M | 692,486 | 760,825 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM PAR $.01 · position key pos:14207 · issuer key iss:973 | ADD | +$5.1M | +62,721 | $84.2M | $89.3M | 483,589 | 546,310 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:13067 · issuer key iss:210 | TRIM | −$16.4M | −51,668 | $104M | $87.8M | 571,226 | 519,558 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:11660 · issuer key iss:1893 | ADD | +$37.5M | +457,177 | $42.3M | $79.8M | 917,115 | 1,374,292 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:12048 · issuer key iss:665 | ADD | +$14.2M | +9,765 | $62.3M | $76.5M | 673,082 | 682,847 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:11219 · issuer key iss:1925 | ADD | −$4.7M | +5,075 | $78.7M | $74.0M | 487,636 | 492,711 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:16286 · issuer key iss:1862 | ADD | −$6.5M | +1,855 | $77.7M | $71.2M | 95,940 | 97,795 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM CL A · position key pos:18003 · issuer key iss:1117 | ADD | +$32.8M | +432,639 | $36.4M | $69.2M | 1,970,459 | 2,403,098 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: CL A · position key pos:11148 · issuer key iss:1805 | ADD | −$22.3M | +2,629 | $88.3M | $66.0M | 2,486,040 | 2,488,669 |
Flags: no row carries a flag.
1–20 of the 100 changes on this page
1–100 of 307 changes
Mark-to-market only (no share change) · 7
Positions whose share count is identical in both quarters; the value changed with price, not with a decision.
| The reviewed ticker for the filed issuer name and share class, the same mapping the Reported positions table uses. Symbols are never inferred from names; — means no reviewed mapping. | position matched across quarters by exact reported CUSIP over a registry gap — never a name match | NEW / ADD / TRIM / EXIT by share count · NO CHANGE = same shares; the value moved with price, so never an ADD or a TRIM · EXIT = absent this quarter (disposed, delisted, confidential, or reported by an affiliate) — the filing does not say which · NO PRIOR = no comparable prior quarter on record (a first filing, or a quarter filed inside an affiliate's report), so not called a new stake · n/c = not classifiable: value undisclosed on one side of the pair, or neither shares nor value can classify it · †v: the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE | derived by Public Filings from the published data; “no value” means the source did not disclose a usable value — never zero | Prev value | Curr value | Prev shares | Curr shares | |
|---|---|---|---|---|---|---|---|---|
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:11517 · issuer key iss:1003 | NO CHANGE | −$2.3M | 0 | $45.5M | $43.2M | 575,000 | 575,000 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:17822 · issuer key iss:1820 | NO CHANGE | −$1.5M | 0 | $32.8M | $31.3M | 2,622,306 | 2,622,306 |
| — | share class as filed: COM · position key sid:sec:prov:1910147dd0682cb840152de5838d5484 · issuer key cusip6:55287L | NO CHANGE | −$1.5M | 0 | $28.1M | $26.6M | 890,000 | 890,000 |
| — | share class as filed: COM · position key sid:sec:prov:a4c0ee8cb9f5ffef6a4d9929cac1aeee · issuer key cusip6:45258H | NO CHANGE | +$9.9M | 0 | $13.3M | $23.2M | 2,549,019 | 2,549,019 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:15725 · issuer key iss:172 | NO CHANGE | −$1.4M | 0 | $24.6M | $23.2M | 370,000 | 370,000 |
| — | share class as filed: COM · position key sid:sec:prov:48ac0f50c981e01f7c5af17d58a117cf · issuer key cusip6:67080M | NO CHANGE | −$4.5M | 0 | $24.6M | $20.1M | 1,297,893 | 1,297,893 |
| a reviewed mapping row for this filed issuer name and share class (never inferred from the name) | share class as filed: COM · position key pos:15014 · issuer key iss:1487 | NO CHANGE | −$2.3M | 0 | $17.5M | $15.2M | 737,694 | 737,694 |
Flags: no row carries a flag.
Holdings without a security ID are counted, not compared. Method ↗
Reported positions — 2026-03-31
278 positionsViewThis build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.
| This list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names. | a position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing | Share of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets. | value undisclosed on the filing: retained and counted, excluded from sums, never shown as $0 | Shares | Wt |
|---|---|---|---|---|---|
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GUARDANT HEALTH INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $218M | 2,362,379 | 3.6% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TRANE TECHNOLOGIES PLC · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $169M | 406,555 | 2.8% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | LAM RESEARCH CORP · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $147M | 688,402 | 2.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MIRUM PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $130M | 1,408,871 | 2.2% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TARGA RES CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $126M | 502,287 | 2.1% | |
| — | XOMETRY INC · CLASS A COM CUSIP 98423F109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $121M | 2,960,239 | 2.0% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GE VERNOVA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $116M | 133,200 | 1.9% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | OLD DOMINION FREIGHT LINE IN · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $115M | 591,691 | 1.9% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SCHOLAR ROCK HLDG CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $108M | 2,197,385 | 1.8% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ARGENX SE · SPONSORED ADR CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $91.7M | 125,657 | 1.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ASML HLDG NV · N Y REGISTRY SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $89.9M | 68,110 | 1.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | IRHYTHM HOLDINGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $89.8M | 760,825 | 1.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INSMED INC · COM PAR $.01 CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $89.3M | 546,310 | 1.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AXSOME THERAPEUTICS INC. · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $87.8M | 519,558 | 1.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VAXCYTE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $79.8M | 1,374,292 | 1.3% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ENTERGY CORP NEW · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $76.5M | 682,847 | 1.3% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VISTRA CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $74.0M | 492,711 | 1.2% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UNITED RENTALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $71.2M | 97,795 | 1.2% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | LIBERTY ENERGY INC · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $69.2M | 2,403,098 | 1.1% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TOAST INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $66.0M | 2,488,669 | 1.1% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | METTLER TOLEDO INTERNATIONAL · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $64.0M | 50,751 | 1.1% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MONOLITHIC PWR SYS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $63.4M | 58,154 | 1.0% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ROYALTY PHARMA PLC · SHS CLASS A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $62.6M | 1,312,534 | 1.0% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NVENT ELEC PLC · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $61.6M | 523,557 | 1.0% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WILLIAMS COS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $60.5M | 832,248 | 1.0% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NASDAQ INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $60.2M | 711,839 | 1.0% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GENERAC HLDGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $59.9M | 306,838 | 1.0% | |
| — | BETA BIONICS INC · COM CUSIP 08659B102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $59.6M | 5,945,488 | 1.0% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | D R HORTON INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $59.0M | 430,871 | 1.0% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | KLA CORP · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $57.8M | 39,639 | 1.0% | |
| — | BELITE BIO INC · SPONSORED ADS CUSIP 07782B104 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $57.0M | 357,650 | 0.9% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | LATTICE SEMICONDUCTOR CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $56.6M | 611,138 | 0.9% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PROLOGIS INC. · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $56.1M | 427,133 | 0.9% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TRANSMEDICS GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $54.5M | 548,824 | 0.9% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DT MIDSTREAM INC · COMMON STOCK CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $54.1M | 401,951 | 0.9% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NISOURCE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $53.3M | 1,143,590 | 0.9% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | KYMERA THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $52.2M | 626,925 | 0.9% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | RB GLOBAL INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $50.6M | 528,143 | 0.8% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WASTE CONNECTIONS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $50.3M | 309,927 | 0.8% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | OREILLY AUTOMOTIVE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $49.8M | 539,880 | 0.8% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | QUANTA SVCS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $49.0M | 89,386 | 0.8% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | COLLEGIUM PHARMACEUTICAL INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $47.1M | 1,424,282 | 0.8% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | APOGEE THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $46.9M | 557,423 | 0.8% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VULCAN MATLS CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $46.2M | 169,572 | 0.8% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NVIDIA CORPORATION · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $44.7M | 259,419 | 0.7% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | EASTGROUP PPTYS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $43.6M | 235,730 | 0.7% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | IONIS PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $43.2M | 575,000 | 0.7% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | STERIS PLC · SHS USD CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $43.0M | 194,635 | 0.7% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PALO ALTO NETWORKS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $40.4M | 252,151 | 0.7% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | LOWES COS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $40.2M | 170,635 | 0.7% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ROLLINS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $40.2M | 753,499 | 0.7% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ELEMENT SOLUTIONS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $39.8M | 1,171,467 | 0.7% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FERGUSON ENTERPRISES INC · COMMON STOCK NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $39.3M | 169,460 | 0.7% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HUNTINGTON BANCSHARES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $39.3M | 2,533,502 | 0.6% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CHEWY INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $38.1M | 1,412,290 | 0.6% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TERADYNE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $37.6M | 127,466 | 0.6% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GLOBAL E ONLINE LTD · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $37.6M | 1,218,345 | 0.6% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TALEN ENERGY CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $37.4M | 117,183 | 0.6% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FASTENAL CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $36.9M | 797,585 | 0.6% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ABIVAX SA · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $35.7M | 320,576 | 0.6% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ROPER TECHNOLOGIES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $33.8M | 95,661 | 0.6% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HOULIHAN LOKEY INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $33.8M | 236,136 | 0.6% | |
| — | CELLDEX THERAPEUTICS INC NEW · COM NEW CUSIP 15117B202 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $32.9M | 1,037,000 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BRIDGEBIO PHARMA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $32.5M | 437,130 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | APPLIED INDL TECHNOLOGIES IN · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $32.1M | 121,287 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CYTOKINETICS INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $31.6M | 479,098 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TREVI THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $31.3M | 2,622,306 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DEXCOM INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $31.1M | 495,003 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AXON ENTERPRISE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $29.6M | 69,843 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GENEDX HOLDINGS CORP · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $29.5M | 459,015 | 0.5% | |
| — | PALVELLA THERAPEUTICS INC NE · COM CUSIP 697947109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $29.0M | 233,248 | 0.5% | |
| — | KESTRA MED TECHNOLOGIES LTD · SHS CUSIP G52441105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $28.8M | 1,445,864 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DATADOG INC · CL A COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $28.3M | 239,835 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CELCUITY INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.8M | 243,899 | 0.5% | |
| — | EVOMMUNE INC · COM SHS CUSIP 30054Y107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $27.8M | 1,209,129 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INTUITIVE SURGICAL INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.6M | 59,942 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MSCI INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.5M | 51,068 | 0.5% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BAKER HUGHES COMPANY · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $26.7M | 438,017 | 0.4% | |
| — | MBX BIOSCIENCES INC · COM CUSIP 55287L101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $26.6M | 890,000 | 0.4% | |
| — | CENTESSA PHARMACEUTICALS PLC · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $26.5M | 668,142 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SIONNA THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.9M | 645,530 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FRONTDOOR INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.7M | 486,232 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | EQT CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.5M | 399,975 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SITIME CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.4M | 73,665 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | REVOLUTION MEDICINES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.4M | 261,425 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DISC MEDICINE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.3M | 395,572 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CG ONCOLOGY INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.0M | 369,985 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WEC ENERGY GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.2M | 209,072 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VERTIV HOLDINGS CO · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.8M | 95,010 | 0.4% | |
| — | IMMIX BIOPHARMA INC · COM CUSIP 45258H106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $23.2M | 2,549,019 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ARROWHEAD PHARMACEUTICALS IN · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.2M | 370,000 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INTERNATIONAL PAPER CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.0M | 645,438 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UL SOLUTIONS INC · CLASS A COM SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.8M | 267,774 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MOTOROLA SOLUTIONS INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.8M | 52,581 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SHERWIN WILLIAMS CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.8M | 71,124 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PENTAIR PLC · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.5M | 259,595 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HALLIBURTON CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.2M | 568,546 | 0.4% | |
| verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CONSTELLATION ENERGY CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.1M | 78,108 | 0.4% | |
| — | OVID THERAPEUTICS INC · COM CUSIP 690469101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $22.0M | 9,916,911 | 0.4% | |
| — | ADC THERAPEUTICS SA · SHS CUSIP H0036K147 quarter ended 2026-03-31 filed filed 2026-05-15 +45d ticker not yet mapped | $21.4M | 5,701,655 | 0.4% |
1–20 of the 100 positions on this page
1–100 of 278 positions · page 1 of 3
One line per issuer, largest first — open a line for its reported rows. Grouping ↗
Book shape
Tick = median of the 8,748 tracked filers with a 2026-03-31 book (the index median: the 8,662 with a complete book). Concentration uses reported 13F long value, not total assets; the index is withheld when any position lacks a value.- 40.5%below median 80.0%
- integer Herfindahl–Hirschman index in basis points over disclosed position values
- 108 bpsbelow median 446 bps
- holdings with no disclosed value (undisclosed, or unreadable on the filing) — kept and counted, never shown as zero
- 278 / 278median book 97.5 positions
314 quarter-over-quarter rows
Filing history
| Period | Source |
|---|---|
| 2026-03-31 | EDGAR ↗ |
Complete source filings on SEC EDGAR
The filing on EDGAR is the record, including any filed after this build.
Open EVENTIDE ASSET MANAGEMENT, LLC's 13F filings on SEC EDGAR ↗A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗
13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.
Positions are quarter-end snapshots filed up to 45 days late — not current holdings: a position may have changed or closed since the quarter ended.
Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars; each record notes its original unit.
Affiliated managers may report the same position, so one position can appear under more than one filer.
Positions under confidential treatment may be omitted until a later amendment discloses them.
These are disclosures, not investment advice.